A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States

被引:3
作者
Crocco, Elizabeth [1 ,2 ]
Curiel-Cid, Rosie E. [1 ,2 ]
Kitaigorodsky, Marcela [1 ]
Gonzalez-Jimenez, Christian J. [1 ]
Zheng, Diane [1 ]
Duara, Ranjan [2 ,3 ]
Loewenstein, David A. [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Ctr Cognit Neurosci & Aging, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
[2] 1Florida Alzheimers Dis Res Ctr, Miami, FL USA
[3] Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Memory Disorders, Miami, FL USA
关键词
Amyloid; biomarkers; cognitive screening; intrusion errors; mild cognitive impairment; neuroimaging; preclinical Alzheimer's disease; semantic interference; structural MRI; MILD COGNITIVE IMPAIRMENT; PROACTIVE SEMANTIC INTERFERENCE; ADAS-COG; DEMENTIA; RESPONSIVENESS; VALIDATION; GUIDELINES; RECOVERY; REGIONS; MEMORY;
D O I
10.3233/JAD-200790
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) is an increasingly utilized cognitive stress test designed to identify early cognitive changes associated with incipient neurodegenerative disease. Objective: To examine previously derived cut-points for cognitively unimpaired older adults that were suggestive of performance impairment on multiple subscales of the LAS SI-L. These cut-points were applied to a new sample of older adults who were cognitive healthy controls (HC: n= 26) and those on the Alzheimer's disease (AD) continuum from early stage mild cognitive impairment (EMCI: n= 28), late stage MCI (LMCI: n= 18) to mild AD (AD: n= 27). Methods: All participants were administered the LAS SI-L. All cognitively impaired participants were PET amyloid positive which likely reflects underlying AD neuropathology, while cognitively normal counterparts were deemed to have amyloid negative scans. Results: There was a monotonic relationship between the number of deficits on LAS SI-L subscales and independent classification of study groups with greater severity of cognitive impairment. Importantly, taken together, impairment on maximum learning ability and measures of proactive semantic interference (both reflected by cued recall and intrusion errors) correctly classified 74.1% of EMCI, 94.4% of LMCI, and 96.3% of AD. Only 7.7% of HC were incorrectly classified as having impairments. Conclusion: A modest number of LASSI-L subscales taking approximately 8 minutes to administer, had excellent discriminative ability using established cut-offs among individuals with presumptive stages of AD. This has potential implications for both clinical practice and clinical research settings targeting AD during early prodromal stages.
引用
收藏
页码:789 / 799
页数:11
相关论文
共 50 条
  • [21] Phenomenological Characterization of Memory Complaints in Preclinical and Prodromal Alzheimer's Disease
    Buckley, Rachel F.
    Ellis, Kathryn A.
    Ames, David
    Rowe, Christopher C.
    Lautenschlager, Nicola T.
    Maruff, Paul
    Villemagne, Victor L.
    Macaulay, S. Lance
    Szoeke, Cassandra
    Martins, Ralph N.
    Masters, Colin L.
    Savage, Greg
    Rainey-Smith, Stephanie R.
    Rembach, Alan
    Saling, Michael M.
    NEUROPSYCHOLOGY, 2015, 29 (04) : 571 - 581
  • [22] Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease
    Goldstein, Felicia C.
    Loring, David W.
    Thomas, Tiffany
    Saleh, Sabria
    Hajjar, Ihab
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (02) : 507 - 514
  • [23] The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
    Bos, Isabelle
    Vos, Stephanie J.
    Froelich, Lutz
    Kornhuber, Johannes
    Wiltfang, Jens
    Maier, Wolfgang
    Peters, Oliver
    Ruether, Eckhart
    Engelborghs, Sebastiaan
    Niemantsverdriet, Ellis
    De Roeck, Ellen Elisa
    Tsolaki, Magda
    Freund-Levim, Yvonne
    Johannsen, Peter
    Vandenberghe, Rik
    Lleo, Alberto
    Alcolea, Daniel
    Frisoni, Giovanni B.
    Galluzzi, Samantha
    Nobili, Flavio
    Morbelli, Silvia
    Drzezga, Alexander
    Didic, Mira
    van Berckel, Bart N.
    Salmon, Eric
    Bastin, Christine
    Dauby, Solene
    Santana, Isabel
    Baldeiras, Ines
    de Mendonca, Alexandre
    Silva, Dina
    Wallin, Anders
    Nordlund, Arto
    Coloma, Preciosa M.
    Wientzek, Angelika
    Alexander, Myriam
    Novak, Gerald P.
    Gordon, Mark Forrest
    Wallin, Asa K.
    Hampel, Harald
    Soininen, Hilkka
    Herukka, Sanna-Kaisa
    Scheltens, Philip
    Verhey, Frans R.
    Visser, Pieter Jelle
    NEUROBIOLOGY OF AGING, 2017, 56 : 33 - 40
  • [24] Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
    Park, Jung Eun
    Choi, Kyu Yeong
    Kim, Byeong C.
    Choi, Seong-Min
    Song, Min-Kyung
    Lee, Jang Jae
    Kim, Jahae
    Song, Ho-Chun
    Kim, Hoo-Won
    Ha, Jung-Min
    Seo, Eun Hyun
    Song, Woo Keun
    Park, Sung-Gyoo
    Lee, Jung Sup
    Lee, Kun Ho
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2019, 9 (01): : 100 - 113
  • [25] A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer's Disease
    Laurens, Brice
    Planche, Vincent
    Cubizolle, Stephanie
    Declerck, Lea
    Dupouy, Sandrine
    Formaglio, Maite
    Koric, Lejla
    Seassau, Magali
    Tilikete, Caroline
    Vighetto, Alain
    Ceccaldi, Mathieu
    Tison, Francois
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (02) : 613 - 621
  • [26] Biomarkers and Functional Decline in Prodromal Alzheimer's Disease
    Robb, Catherine
    Udeh-Momoh, Chinedu
    Wagenpfeil, Stefan
    Schoepe, Jakob
    Alexopoulos, Panagiotis
    Perneczky, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (01) : 69 - 78
  • [27] Markers of prodromal Alzheimer's disease
    de Souza, L. C.
    Sarazin, M.
    Uspenskaya, O.
    Habert, M. -O.
    Lamari, F.
    Lehericy, S.
    Dubois, B.
    REVUE NEUROLOGIQUE, 2012, 168 (11) : 815 - 824
  • [28] Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease
    Ulbl, Janina
    Rakusa, Martin
    ACTA NEUROLOGICA BELGICA, 2022, 122 (03) : 695 - 702
  • [29] The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis
    Szalardy, Levente
    Zadori, Denes
    Klivenyi, Peter
    Vecsei, Laszlo
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 373 - 392
  • [30] Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET
    Lopez-de-Eguileta, Alicia
    Lage, Carmen
    Lopez-Garcia, Sara
    Pozueta, Ana
    Garcia-Martinez, Maria
    Kazimierczak, Martha
    Bravo, Maria
    de Arcocha-Torres, Maria
    Banzo, Ignacio
    Jimenez-Bonilla, Julio
    Cervero, Andrea
    Goikoetxea, Alexander
    Rodriguez-Rodriguez, Eloy
    Sanchez-Juan, Pascual
    Casado, Alfonso
    PLOS ONE, 2020, 15 (09):